Notice of EGM

AstraZeneca PLC
12 April 2000


SYNGENTA

AstraZeneca announced today that it expects to hold an Extraordinary General
Meeting on Wednesday 11th October 2000 to enable shareholders to vote on the
proposed transaction relating to the establishment of Syngenta announced on
2nd December 1999.  

The transaction is undergoing Phase 2 Review by the European and US
Authorities and approval is anticipated during the second half of this year.


G H R Musker
Company Secretary